Technical analyst Sudarshan Sukhani has suggested three BUY calls and one SELL call for today’s session, suggesting bullish sentiment.

Technical analyst Sudarshan Sukhani has two stocks on his selling list and two on his buying list for the traders today.

Epic Research recommends three stocks for investors....

Glenmark Pharmaceuticals Ltd has announced that its Swiss unit, Glenmark Pharmaceuticals SA, has received USD 15 Million as milestone fees from Forest Laboratories, its North American partner, for an anti-asthma drug Oglemilast molecule.

Both companies are working together to initiate additional studies for further longer term development of oglemilast, including a Phase II study in Asthma.